Algernon Pharmaceuticals Appoints Dr. Mark Swaim MD, PhD to its Medical and Scientific Advisory Board Biotech Investing
Final Results of National Institute of Allergy and Infectious Diseases' ACTT-1 Trial Published in New England Journal of Medicine Expand Clinical Benefits of Veklury® for the Treatment of COVID-19 Biotech Investing
Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure Biotech Investing
Gilead Sciences Signs Joint Procurement Agreement With the European Commission for Veklury® Biotech Investing
Naturally Splendid CEO: Our Focus on Plant-based Nutrition is Our Competitive Advantage Video Interview
Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business Biotech Investing
Health Canada Approves ZEPOSIA®, an Oral Treatment for Relapsing Remitting Multiple Sclerosis Biotech Investing
Opdivo Plus Chemotherapy Shows Statistically Significant Improvement in Pathologic Complete Response as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Biotech Investing
BriaCell to Present Clinical Findings at the 2020 San Antonio Breast Cancer Symposium®, December 9 - 11 Biotech Investing
